DexCom, Inc.

DC4.F·Frankfurt·Healthcare
Compare
78.00−0.60 (−0.76%)today
As of Nov 5, 8:10 AM CET · May be delayed up to 15 min · EUR

Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.

Key statistics

Previous close78.60
Open78.00
Day range—
52-week range46.8879.20
Off day high0.00%
Off 52-week high−1.52%
Volume127
Avg. volume (3M)62.00
Market cap29.09B
EPS (TTM)2.19
Forward P/E22.10
P/E ratio (TTM)35.62
Dividend yield—
Beta (5Y)1.44
Shares outstanding372.95M
Short interest—
Earnings dateOct 29, 2026
Analyst target—
Profit margin19.42%

Against its peers

Compare in full ›
DC4.F 2235.HK GEHC PODD TNDM SENS
Market cap 29.09B 2.62B 38.80B 11.44B 1.33B 476.92M
P/E (TTM) 35.6 28.9 18.1 27.0 — —
Forward P/E 22.1 18.9 15.6 21.4 119.8 -4.6
Price/book 12.9 1.2 3.3 7.7 10.2 5.3
Dividend yield — — 0.19% — — —
1-year change +43.27% −4.24% +6.68% −50.75% +20.31% +31.65%
Today −0.76% −0.30% +6.38% +6.56% +7.93% +1.81%

The closest companies by business and industry (Medical Devices). Prices may be delayed up to 15 min.

Latest news

All DC4.F news ›
Markets Daily·

Analysts’ Weekly Ratings Updates for DexCom (DXCM)

Posted by Kim Johansen on Nov 4th, 2026 Several brokerages have updated their recommendations and price targets on shares of DexCom (NASDAQ: DXCM) in the last few weeks: DexCom, Inc develops and commercializes continuous glucose monitoring…

TradingView··3 outletsPositive

DexCom to Launch 15-Day G7 CGM System in Canada This November

Per management, Dexcom G7 15 Day is designed to make glucose monitoring simpler and more seamless for people living with diabetes. The new system combines extended sensor life with accuracy and performance. The product's launch in Canada…

More from 2 other outlets
Seeking Alpha·Positive

DexCom: Improving Patient Access Makes It A Long-Term Buy

DexCom's recurring sensor model synergizes nicely with wider diabetes access thanks to Medicare. Find out why I rate DXCM stock a Buy. - DXCM's recurring sensor model synergizes nicely with wider diabetes access thanks to Medicare. - In…

TradingView·Positive

DexCom Stock Up on Q3 Earnings & Revenue Beat, Margins Rise

DexCom, Inc. DXCM reported third-quarter 2026 adjusted earnings per share (EPS) of 73 cents, which beat the Zacks Consensus Estimate of 66 cents by 10.6%. The company reported adjusted EPS of 61 cents per share in the prior-year quarter.…

From the 4Search news index, newest first.

In the news

67mentions in 30 days
67with it in the headline
Positivesentiment

Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 67 articles, not a forecast.

Market data is provided for information only and comes from free public sources. Prices may be delayed up to 15 minutes; data may be incomplete or inaccurate. Nothing on this page is investment advice or a recommendation to buy or sell any security. News and coverage analytics are drawn from the 4SEARCH.business index. Terms of use. How to use Finance